Market data

Select a section

Oxford Cannabinoid Technologies Holdings

(OCTP)
Sector: Pharmaceuticals & Biotechnology
0.12p
-0.01p -4.17
Last updated: 16:57:05

Company News Headlines

Date Time Headline Source
06/06/2024 07:00 Cancellation of Listing RNS
31/05/2024 07:00 Updated Shareholder Engagement RNS
17/05/2024 16:30 Updated Shareholder Information RNS
08/05/2024 07:00 Intended Cancellation of Listing RNS
11/04/2024 11:26 Appointment of Phase I Clinical Trial CRO RNS
18/03/2024 07:00 Appointment of Hybridan as Adviser RNS
29/02/2024 07:02 Directorate Appointment RNS
29/02/2024 07:01 Directorate Changes RNS
29/02/2024 07:00 Total Voting Rights RNS
28/02/2024 17:35 TR-1: NOTIFICATION OF MAJOR HOLDINGS RNS
28/02/2024 17:34 TR-1: NOTIFICATION OF MAJOR HOLDINGS RNS
28/02/2024 17:34 TR-1: NOTIFICATION OF MAJOR HOLDINGS RNS
26/02/2024 13:07 Directors’ Dealings RNS
19/02/2024 13:52 Result of General Meeting RNS
16/02/2024 07:00 Completion of Capital Reorganisation RNS
15/02/2024 07:00 Subscription RNS
14/02/2024 12:53 Capital Reorganisation RNS
02/02/2024 15:17 Notice of General Meeting & Posting of Circular RNS
02/02/2024 15:13 Convertible Loan Note Agreements RNS
30/01/2024 07:04 Fundraising and Proposed Capital Reorganisation RNS
30/01/2024 07:02 R&D Tax Credit RNS
30/01/2024 07:00 Half-year Report RNS
23/01/2024 07:00 Notice of Results RNS
10/01/2024 07:00 Patent Applications RNS
14/11/2023 07:00 Directorate Appointment RNS
24/10/2023 07:00 TR-1: Notification of major holdings RNS
20/10/2023 07:01 TR-1: Notification of major holdings RNS
20/10/2023 07:00 Director Dealing RNS
10/10/2023 07:00 Phase I Clinical Trial Results RNS
29/09/2023 07:00 Result of AGM RNS
25/09/2023 07:00 Final Dose Administered RNS
05/09/2023 16:18 Notice of AGM RNS
31/08/2023 07:00 2023 Final Results RNS
22/08/2023 07:00 Notice of Results RNS
27/07/2023 07:00 First Dose Administered & Pain Specialist Adviser RNS
17/07/2023 13:16 Director/PDMR Share Purchases RNS
17/07/2023 07:00 Expansion into oncology RNS
08/06/2023 07:00 Appointment of Chief Medical Officer RNS
17/05/2023 07:00 MHRA & REC 2 Approval for Phase 1 Clinical Trial RNS
12/04/2023 07:00 Directorate Change, Renewal of Licence & Update RNS
14/03/2023 14:05 Second Price Monitoring Extn RNS
14/03/2023 14:00 Price Monitoring Extension RNS
13/03/2023 16:35 Price Monitoring Extension RNS
07/03/2023 11:05 Second Price Monitoring Extn RNS
07/03/2023 11:00 Price Monitoring Extension RNS
06/03/2023 11:05 Second Price Monitoring Extn RNS
06/03/2023 11:00 Price Monitoring Extension RNS
25/01/2023 12:09 Holding in Company RNS
23/01/2023 07:00 Half-year Report RNS
16/01/2023 07:00 Appointment of General Counsel & Notice of Results RNS

Market data

Select a section